Report Code : CVMI240717001 | Published Date : July 17, 2024
Market Overview
Transcatheter Aortic Valve Implantation (TAVI), also known as Transcatheter Aortic Valve Replacement (TAVR), is a minimally invasive procedure used to treat severe aortic stenosis in patients considered to be at high or intermediate surgical risk. The procedure involves delivering a collapsible bioprosthetic valve via catheter—typically transfemorally—to replace the diseased native valve. TAVI has rapidly gained clinical acceptance due to shorter recovery times, reduced hospital stays, and expanding indications for low-risk patients. With ongoing device innovation, growing elderly populations, and favorable reimbursement pathways, the global TAVI market is poised for robust expansion.
Market Size and Forecast
Year |
Market Value (USD Billion) |
Notes |
2019 |
3.12 |
Includes procedure revenue, valve units, and delivery systems |
2024 |
6.24 |
CAGR 14.8 % (2019–2024), driven by low-risk patient approvals and aging demographics |
2031 |
13.12 |
CAGR 11.2 % (2024–2031); potential high-growth scenario: USD 15.1 billion if expanded indications cover bicuspid valves and younger populations |
Adoption Outlook – More than 350,000 TAVI procedures are anticipated worldwide in 2025, increasing to over 650,000 by 2031 with improved access and expanded training.
Market Drivers
- Growing elderly population – Aortic stenosis incidence increases with age; TAVI provides lower-risk options.
- Expanding indications – TAVI is now approved for low-risk and intermediate-risk surgical candidates in the U.S., EU, and Japan.
- Minimally invasive benefits – Faster recovery and reduced ICU stays make it appealing for both patients and hospitals.
- Technological advances – Smaller delivery systems, repositionable valves, and improved imaging integration support outcomes.
- Robust clinical evidence – Trials like PARTNER 3 and Evolut Low Risk reinforce safety in younger patients.
Market Challenges
- High device and procedure cost limits access in LMICs and non-reimbursed markets.
- Stroke and pacemaker dependency risk remain post-TAVI complications.
- Training & credentialing – Steep learning curve requires dedicated heart teams and hybrid ORs.
- Durability concerns – Valve longevity beyond 10–15 years remains under study for younger recipients.
- Access route limitations – Vascular anatomy can restrict transfemoral access in 10–15 % of patients.
Competitive Landscape
Company / Organisation |
2024 Share |
Core Strengths |
Recent Moves |
Edwards Lifesciences |
35 % |
SAPIEN valve family; balloon-expandable platforms |
FDA approval for SAPIEN X4 in low-risk cohort (Q1 2025) |
Medtronic |
32 % |
Evolut PRO+, self-expanding valves, alternative access kits |
Launched Evolut FX with improved delivery precision (Q3 2024) |
Boston Scientific |
12 % |
LOTUS Edge repositionable valve (relaunched), customizable sizing |
CE mark reinstated after redesign (Q2 2024) |
Abbott |
6 % |
Portico valve system with FlexNav delivery |
Gained FDA IDE for new Navitor Plus valve (Q4 2024) |
Others (JenaValve, Meril Life, Venus Medtech) |
15 % |
China & India-based firms scaling access & local manufacturing |
VenusP-Valve approved for pulmonic use in Europe (Q1 2025) |
Market Segmentation
Segment |
2024 Share |
CAGR ’24–’31 |
By Valve Type |
||
Balloon-Expandable Valves |
49 % |
10.4 % |
Self-Expanding Valves |
XX % |
XX % |
Mechanically Expandable |
XX% |
9.2 % |
By Access Route |
||
Transfemoral |
XX % |
XX % |
Transapical & Others |
XX % |
7.4 % |
By End User |
||
Hospitals with Hybrid ORs |
XX % |
10.9 % |
Ambulatory Cardiac Centers |
27 % |
XX % |
Academic & Research Institutions |
XX % |
11.8 % |
Regional Analysis
North America (42 %) – Mature market with Medicare coverage; over 500 TAVI centers in the U.S. alone.
Europe (XX %) – Strong public insurance support; Germany, France, and UK lead procedural volumes.
Asia-Pacific (XX %) – Fastest CAGR 14.2 %; Japan and China expand TAVI training and reimbursement.
Latin America (XX %) – Brazil and Argentina pilot public TAVI programs; private sector drives early adoption.
Middle East & Africa (XX%) – UAE and Saudi Arabia invest in TAVI-ready cardiac infrastructure.
Technology & Innovation
- Next-gen repositionable valves improve placement accuracy and reduce paravalvular leak.
- 3D navigation integration optimises catheter alignment and valve deployment.
- Low-profile delivery systems reduce access-site trauma and expand femoral eligibility.
- Polymer leaflet valves under study for extended durability.
AI-assisted imaging improves preprocedural planning and valve sizing.
Regulatory Landscape
- FDA approvals for low-risk patients expand indications; CE mark harmonised under MDR.
- China NMPA and India CDSCO fast-tracking indigenous valve systems.
- Global Valve Registry (GVR) mandates real-world data submission for long-term surveillance.
- EACTS & ACC guidelines provide patient selection protocols across age and risk strata.
Recent Developments (Q4 2023–Q2 2025)
- Edwards received FDA approval for SAPIEN X4 valve with AI sizing module (Q1 2025).
- Medtronic launched Evolut FX in Japan and India (Q4 2024).
- Boston Scientific resumed LOTUS Edge EU rollout after redesign (Q2 2024).
- Abbott initiated pivotal trial for Navitor Plus valve in bicuspid anatomy (Q4 2024).
- Venus Medtech gained CE mark for pulmonary TAVI solution (Q1 2025).
Strategic Outlook
Hospitals should expand hybrid OR capacity and build TAVI-specific heart teams to support case growth. Device firms must invest in next-generation, low-risk valves, regional training programs, and outpatient workflow tools. Public health agencies should update reimbursement schedules to ensure equitable access across demographics.
Methodology
Clearview Market Insights aggregated registry data, OEM unit sales, payer coverage maps, and 102 interviews with interventional cardiologists, CV surgeons, and payor-policy experts across 21 countries. Projections incorporate patient-risk stratification, infrastructure build-outs, and guideline changes.
Reasons To Buy

Scope

- Edwards Lifesciences Corporation
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- JenaValve Technology, Inc.
- Meril Life Sciences Pvt. Ltd.
- Venus Medtech (Hangzhou) Inc.
- Peijia Medical Limited
- MicroPort Scientific Corporation
- Bracco S.p.A.
- LivaNova PLC (formerly Sorin Group)
- CryoLife, Inc.
- Direct Flow Medical, Inc.
- Transcatheter Technologies GmbH
- HLT, Inc.
1. Global Transcatheter Aortic Valve Implantation (TAVI) Market Research Report |
1.1 Study Objectives |
1.2 Transcatheter Aortic Valve Implantation (TAVI) - Overview |
1.3 Reason to Read This Report |
1.4 Methodology and Forecast Analysis |
2. Global Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Preface |
2.1 Global Transcatheter Aortic Valve Implantation (TAVI) Market Research Report – Detailed Scope and Definitions |
2.1.1 By Surgery Method |
2.1.2 By Valve Frame Material |
2.1.3 By Valve Size |
2.1.4 By Valve Leaflets Material |
2.1.5 By End User |
2.1.6 By Region |
3. Global Transcatheter Aortic Valve Implantation (TAVI) Dynamics |
3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers |
3.2. Restraints – By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, By Country |
3.3. Opportunities – By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, By Country |
3.4. Trends – By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, By Country |
3.5. PEST Analysis |
3.6. Porters Five Rule Analysis |
3.7. Company’s Share Analysis (CSA) by Region or By Country |
3.8. Global Transcatheter Aortic Valve Implantation (TAVI) Market Research Report – DROTs Impact Analysis |
3.9. Epideamology Data By Country Data |
4.0. Clinical Trails, Pipeline and Forecast Analysis |
4. Global Transcatheter Aortic Valve Implantation (TAVI) Market Research Report , Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031 |
4.1.Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
4.2.Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%). |
4.3.Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031 |
4.4.Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
5. Global Transcatheter Aortic Valve Implantation (TAVI), By Surgery Method, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
5.1 Transfemoral Implantation |
5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
5.2 Transapical Implantation |
5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
5.3 Transaortic Implantation |
5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
5.4 Transcaval Implantation |
5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
6. Global Transcatheter Aortic Valve Implantation (TAVI), By Valve Frame Material, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
6.1 Nitinol |
6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
6.2 Stainless Steel |
6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
6.3 Cobalt-Chromium |
6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
7. Global Transcatheter Aortic Valve Implantation (TAVI), Valve Size, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
7.1 14 mm to 18 mm |
7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
7.2 18 mm to 22 mm |
7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
7.3 22 mm to 29 mm |
7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
8. Global Transcatheter Aortic Valve Implantation (TAVI), Valve Leaflets Material, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
8.1 Bovine Heart Tissue |
8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
8.2 Cow Heart Tissue |
8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
8.3 Other Valve Leaflets Material |
8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
9. Global Transcatheter Aortic Valve Implantation (TAVI), End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
9.1 Hospitals |
9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
9.2 Ambulatory Surgical Centers |
9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
9.3 Cardiac Catheterization Laboratories |
9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
10. Global Transcatheter Aortic Valve Implantation (TAVI) Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn) |
10.1 North America |
10.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
10.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
10.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
10.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
10.2 Latin America |
10.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
10.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
10.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
10.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
10.3 Europe |
10.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
10.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
10.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
10.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
10.4 Asia-Pacific |
10.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
10.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
10.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
10.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
10.5 Middle East and Africa |
10.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
10.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
10.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
10.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
10.6 Global Transcatheter Aortic Valve Implantation (TAVI) - Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Region, 2024 - 2031 |
11. North America Transcatheter Aortic Valve Implantation (TAVI) Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
11.1 By Surgery Method Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
11.1.1 Transfemoral Implantation |
11.1.2 Transapical Implantation |
11.1.3 Transaortic Implantation |
11.1.4 Transcaval Implantation |
11.2 By Valve Frame Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
11.2.1 Nitinol |
11.2.2 Stainless Steel |
11.2.3 Cobalt-Chromium |
11.3 Valve Size Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
11.3.1 14 mm to 18 mm |
11.3.2 18 mm to 22 mm |
11.3.3 22 mm to 29 mm |
11.4 Valve Leaflets Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
11.4.1 Bovine Heart Tissue |
11.4.2 Cow Heart Tissue |
11.4.3 Other Valve Leaflets Material |
11.5 End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
11.5.1 Hospitals |
11.5.2 Ambulatory Surgical Centers |
11.5.3 Cardiac Catheterization Laboratories |
11.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
11.6.1 USA |
11.6.2 Canada |
11.7 North America Transcatheter Aortic Valve Implantation (TAVI) – Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Country, 2024 - 2031 |
11.8 Regional Trends Analysis |
11.9 North America Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Company Profiles |
11.9.1 Company 1 (USA) |
11.9.2 Company 2 (Canada) |
11.9.3 Company 3 (Canada) |
12. Latin America Transcatheter Aortic Valve Implantation (TAVI) Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
12.1 By Surgery Method Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
12.1.1 Transfemoral Implantation |
12.1.2 Transapical Implantation |
12.1.3 Transaortic Implantation |
12.1.4 Transcaval Implantation |
12.2 By Valve Frame Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
12.2.1 Nitinol |
12.2.2 Stainless Steel |
12.2.3 Cobalt-Chromium |
12.3 Valve Size Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
12.3.1 14 mm to 18 mm |
12.3.2 18 mm to 22 mm |
12.3.3 22 mm to 29 mm |
12.4 Valve Leaflets Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
12.4.1 Bovine Heart Tissue |
12.4.2 Cow Heart Tissue |
12.4.3 Other Valve Leaflets Material |
12.5 End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
12.5.1 Hospitals |
12.5.2 Ambulatory Surgical Centers |
12.5.3 Cardiac Catheterization Laboratories |
12.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
12.6.1 Brazil |
12.6.2 Mexico |
12.6.3 Argentina |
12.6.4 Rest of Latin America |
12.7 Latin America Transcatheter Aortic Valve Implantation (TAVI) – Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Country, 2024 - 2031 |
12.8 Regional Trends Analysis |
12.9 Latin America Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Company Profiles |
12.9.1 Company 1 (Brazil) |
12.9.2 Company 2 (Mexico) |
12.9.3 Company 3 (Mexico) |
13. Europe Transcatheter Aortic Valve Implantation (TAVI) Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
13.1 By Surgery Method Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
13.1.1 Transfemoral Implantation |
13.1.2 Transapical Implantation |
13.1.3 Transaortic Implantation |
13.1.4 Transcaval Implantation |
13.2 By Valve Frame Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
13.2.1 Nitinol |
13.2.2 Stainless Steel |
13.2.3 Cobalt-Chromium |
13.3 Valve Size Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
13.3.1 14 mm to 18 mm |
13.3.2 18 mm to 22 mm |
13.3.3 22 mm to 29 mm |
13.4 Valve Leaflets Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
13.4.1 Bovine Heart Tissue |
13.4.2 Cow Heart Tissue |
13.4.3 Other Valve Leaflets Material |
13.5 End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
13.5.1 Hospitals |
13.5.2 Ambulatory Surgical Centers |
13.5.3 Cardiac Catheterization Laboratories |
13.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
13.6.1 United Kingdom |
13.6.2 Germany |
13.6.3 France |
13.6.4 Spain |
13.6.5 Italy |
13.6.6 Russia |
13.6.7 Rest of Europe |
13.7 Europe Transcatheter Aortic Valve Implantation (TAVI) – Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Country, 2024 - 2031 |
13.8 Regional Trends Analysis |
13.9 Europe Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Company Profiles |
13.9.1 Company 1 (United Kingdom) |
13.9.2 Company 2 (Germany) |
13.9.3 Company 3 (Germany) |
14. Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
14.1 By Surgery Method Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
14.1.1 Transfemoral Implantation |
14.1.2 Transapical Implantation |
14.1.3 Transaortic Implantation |
14.1.4 Transcaval Implantation |
14.2 By Valve Frame Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
14.2.1 Nitinol |
14.2.2 Stainless Steel |
14.2.3 Cobalt-Chromium |
14.3 Valve Size Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
14.3.1 14 mm to 18 mm |
14.3.2 18 mm to 22 mm |
14.3.3 22 mm to 29 mm |
14.4 Valve Leaflets Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
14.4.1 Bovine Heart Tissue |
14.4.2 Cow Heart Tissue |
14.4.3 Other Valve Leaflets Material |
14.5 End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
14.5.1 Hospitals |
14.5.2 Ambulatory Surgical Centers |
14.5.3 Cardiac Catheterization Laboratories |
14.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
14.6.1 China |
14.6.2 Japan |
14.6.3 India |
14.6.4 Australia & New Zealand |
14.6.5 South Korea |
14.6.6 Rest of Asia-Pacific |
14.7 Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) – Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Country, 2024 - 2031 |
14.8 Regional Trends Analysis |
14.9 Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Company Profiles |
14.9.1 Company 1 (China) |
14.9.2 Company 2 (Japan) |
14.9.3 Company 3 (Japan) |
15. Middle East and Africa Transcatheter Aortic Valve Implantation (TAVI) Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
15.1 By Surgery Method Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
15.1.1 Transfemoral Implantation |
15.1.2 Transapical Implantation |
15.1.3 Transaortic Implantation |
15.1.4 Transcaval Implantation |
15.2 By Valve Frame Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
15.2.1 Nitinol |
15.2.2 Stainless Steel |
15.2.3 Cobalt-Chromium |
15.3 Valve Size Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
15.3.1 14 mm to 18 mm |
15.3.2 18 mm to 22 mm |
15.3.3 22 mm to 29 mm |
15.4 Valve Leaflets Material Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
15.4.1 Bovine Heart Tissue |
15.4.2 Cow Heart Tissue |
15.4.3 Other Valve Leaflets Material |
15.5 End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
15.5.1 Hospitals |
15.5.2 Ambulatory Surgical Centers |
15.5.3 Cardiac Catheterization Laboratories |
15.6 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
15.6.1 UAE |
15.6.2 Saudi Arabia |
15.6.3 South Africa |
15.6.4 Egypt |
15.6.5 Israel |
15.6.6 Egypt |
15.6.7 Rest of Middle East and Africa |
15.7 Middle East and Africa Transcatheter Aortic Valve Implantation (TAVI) – Opportunity Analysis Index, By Surgery Method, By Valve Frame Material, Valve Size, Valve Leaflets Material, End User, and Country, 2024 - 2031 |
15.8 Regional Trends Analysis |
15.9 Middle East and Africa Transcatheter Aortic Valve Implantation (TAVI) Market Research Report - Company Profiles |
15.9.1 Company 1 (UAE) |
15.9.2 Company 2 (Saudi Arabia) |
15.9.3 Company 3 (Saudi Arabia) |
16. Competition Landscape |
16.1 Strategic Dashboard of Top Market Players |
16.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis) |
16.2.1 Medtronic plc |
16.2.2 Edwards Lifesciences Corporation |
16.2.3 Boston Scientific Corporation |
16.2.4 Abbott Laboratories |
16.2.5 Meril Life Sciences Pvt. Ltd |
16.2.6 JenaValve Technology Inc |
16.2.8 Venus Medtech |
16.2.9 NVT AG |
16.2.10 HLT |
16.2.12 Transcatheter Technologies GmbH |
16.2.13 JC Medical Inc. |
16.2.15 Braile Biomédica |
16.2.16 Xeltis |
16.2.17 Colibri Heart Valve LLC |
16.2.19 and Micro Interventional Devices Inc. |
17. Data Collection Method and Research Approach |
18. Principal Presumptions and Acronyms |